Abstract
Endogenous fungal endophthalmitis (EFE) caused by disseminated fusariosis is a rare condition that generally has a poor outcome, even with intensive therapy. Here, we describe a case in which this type of EFE was diagnosed with vitreous sampling and was successfully treated with 25-gauge vitrectomy and antifungals, including liposomal amphotericin B and voriconazole. A 16-year-old male patient undergoing treatment for acute myeloid leukemia complained of eye pain and blurred vision in his right eye. Treatment was initiated for a vitreous opacity, possibly associated with herpetic retinitis, but the patient worsened and he was referred to us. Right-eye visual acuity was limited to light perception. We suspected endogenous endophthalmitis and performed 25-gauge vitrectomy with antibiotic perfusion of ceftazidime, vancomycin, and voriconazole. Vitreous culturing revealed the presence of Fusarium solani species complex, and enhanced computed tomography revealed disseminated fusariosis lesions in the lung, spleen, and the soft tissue of the left upper arm. The patient received antifungal treatment with liposomal amphotericin B and voriconazole, and these conditions were eliminated. Visual acuity recovered to 20/400 after additional vitrectomy for tractional retinal detachment and was maintained at this level during the 6-month follow-up period. The success of our treatment allowed the capture of optical coherence tomography images of the retina during fusarium-associated endogenous endophthalmitis and the follow-up period. Furthermore, this case showed that immediate vitrectomy for suspected EFE and intensive treatment can lead to a good clinical outcome.
Similar content being viewed by others
References
Boutati EI, Anaissie EJ. Fusarium, a significant emerging pathogen in patients with hematologic malignancy: ten years’ experience at a cancer center and implications for management. Blood. 1997;90:999–1008.
Martino P, Gastaldi R, Raccah R, Girmenia C. Clinical patterns of Fusarium infections in immunocompromised patients. J Infect. 1994;28(Suppl 1):7–15.
Malavade SS, Mai M, Pavan P, Nasr G, Sandin R, Greene J. Endogenous fusarium endophthalmitis in hematologic malignancy short case series and review of literature. Infect Dis Clin Pract. 2013;21:6–11.
Gabriele P, Hutchins RK. Fusarium endophthalmitis in an intravenous drug abuser. Am J Ophthalmol. 1996;122:119–21.
Bui DK, Carvounis PE. Favorable outcomes of filamentous fungal endophthalmitis following aggressive management. J Ocul Pharmacol Ther. 2016;32:623–30.
Lieberman TW, Ferry AP, Bottone EJ. Fusarium solani endophthalmitis without primary corneal involvement. Am J Ophthalmol. 1979;88:764–7.
Venditti M, Micozzi A, Gentile G, Polonelli L, Morace G, Bianco P, Avvisati G, Papa GMP. Invasive Fusarium solani infections in patients with acute leukemia. Rev Infect Dis. 1988;10:653–60.
Robertson MJ, Socinski MA, Soiffer RJ, Finberg RW, Wilson C, Anderson KC, Bosserman L, Sang DN, Salkin IFRJ. Successful treatment of disseminated Fusarium infection after autologous bone marrow transplantation for acute myeloid leukemia. Bone Marrow Transpl. 1991;8:143–5.
Louie T, el Baba F, Shulman M, Jimenez-Lucho V. Endogenous endophthalmitis due to Fusarium: case report and review. Clin Infect Dis. 1994;18:585–8.
Patel AS, Hemady RK, Rodrigues M, Rajagopalan S, Elman MJ. Endogenous Fusarium endophthalmitis in a patient with acute lymphocytic leukemia. Am J Ophthalmol. 1994;117:363–8.
Tiribelli M, Zaja F, Filı C, Michelutti T, Prosdocimo S, Candoni A, et al. Endogenous endophthalmitis following disseminated fungemia due to Fusarium solani in a patient with acute myeloid leukemia. Eur J Haematol. 2002;68:314–7.
Glasgow BJ, Engstrom RE, Holland GN, Kreiger AE, Wool MG. Bilateral endogenous Fusarium endophthalmitis associated with acquired immunodeficiency syndrome. Arch Ophthalmol. 1996;114:873–7.
Rezai KA, Eliott D, Plous O, Vazquez JA, Abrams GW. Disseminated Fusarium infection presenting as bilateral endogenous endophthalmitis in a patient with acute myeloid leukemia. Arch Ophthalmol. 2005;123:702–3.
Jørgensen JS, Prause JU, Kiilgaard JF. Bilateral endogenous Fusarium solani endophthalmitis in a liver-transplanted patient: a case report. J Med Case Rep. 2014;8:8–10.
Balamurugan S, Khodifad A. Endogenous Fusarium endophthalmitis in diabetes mellitus. Case Rep Ophthalmol Med. 2016;2016:6736413.
White TJ, Bruns T, Lee STJ. Amplification and direct sequencing of fungal ribosomal RNA Genes for phylogenetics. PCR Protoc Guid Methods Appl. 1990;18:315–22.
Glass NL, Donaldson GC. Development of primer sets designed for use with the PCR to amplify conserved genes from filamentous ascomycetes. Appl Environ Microbiol. 1995;61:1323–30.
Staab JF, Balajee SA, Marr KA. Aspergillus section Fumigati typing by PCR-restriction fragment polymorphism. J Clin Microbiol. 2009;47:2079–83.
Geiser DM, del Mar Jiménez-Gasco M, Kang S, Makalowska I, Veeraraghavan N, Ward TJ, et al. FUSARIUM-ID v. 1. 0: A DNA sequence database for identifying Fusarium. Eur J Plant Pathol. 2004;110:473–9.
Martínez-Vázquez C, Fernández-Ulloa J, Bordón J, Sopeña B, de la Fuente J, Ocampo A, et al. Candida albicans endophthalmitis in brown heroin addicts: response to early vitrectomy preceded and followed by antifungal therapy. Clin Infect Dis. 1998;27:1130–3.
Zhang Y-Q, Wang W-J. Treatment outcomes after pars plana vitrectomy for endogenous endophthalmitis. Retina. 2005;25:746–50.
Stanzani M, Tumietto F, Vianelli N, Baccarani M. Update on the treatment of disseminated fusariosis: focus on voriconazole. Ther Clin Risk Manag. 2007;3:1165–73.
Nucci M, Marr KA, Vehreschild MJGT, de Souza CA, Velasco E, Cappellano P, et al. Improvement in the outcome of invasive fusariosis in the last decade. Clin Microbiol Infect. 2014;20:580–5.
Rizzello I, Castagnetti F, Toschi PG, Bertaccini P, Primavera L, Paolucci M, et al. Successful treatment of bilateral endogenous Fusarium solani endophthalmitis in a patient with acute lymphocytic leukemia. Mycoses. 2017;. https://doi.org/10.1111/myc.12697.
Philip A, Odabasi Z, Rodriguez J, Paetznick VL, Chen E, Rex JH, et al. In vitro synergy testing of anidulafungin with itraconazole, voriconazole, and amphotericin B against Aspergillus spp. and Fusarium spp. Antimicrob Agents Chemother. 2005;49:3572–4.
Córdoba S, Rodero L, Vivot W, Abrantes R, Davel G, Vitale RG. In vitro interactions of antifungal agents against clinical isolates of Fusarium spp. Int J Antimicrob Agents. 2008;31:171–4.
Spader TB, Venturini TP, Cavalheiro AS, Mahl CD, Mario DN, Lara VM, et al. In vitro interactions between amphotericin B and other antifungal agents and rifampin against Fusarium spp. Mycoses. 2011;54:131–6.
Martin-Vicente A, Guarro J, Capilla J. Does a triple combination have better activity than double combinations against multiresistant fungi? Experimental in vitro evaluation. Int J Antimicrob Agents. 2017;49:422–6.
Lavine JA, Mititelu M. Multimodal imaging of refractory Candida chorioretinitis progressing to endogenous endophthalmitis. J Ophthalmic Inflamm Infect. 2015;5:24.
Adam CR, Sigler EJ. Multimodal imaging findings in endogenous Aspergillus endophthalmitis. Retina. 2014;34:1914–5.
Mayayo E, Guarro J, Pujol I. Endogenous endophthalmitis by Fusarium solani: an animal experimental model. Med Mycol. 1998;36:249–53.
Acknowledgements
The authors thank Mr. Tim Hilts for reviewing this manuscript.
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflict of interest
The authors declare that they have no conflict of interest.
Ethical Approval
The case presentation conforms to the principles of the Declaration of Helsinki.
Rights and permissions
About this article
Cite this article
Yoshida, M., Kiyota, N., Maruyama, K. et al. Endogenous Fusarium Endophthalmitis During Treatment for Acute Myeloid Leukemia, Successfully Treated with 25-Gauge Vitrectomy and Antifungal Medications. Mycopathologia 183, 451–457 (2018). https://doi.org/10.1007/s11046-017-0221-x
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11046-017-0221-x